Results 141 to 150 of about 18,344 (221)

Outcomes and Usability of Formoterol-Budesonide Delivered Through Synchrobreathe^® in Patients With Chronic Obstructive Pulmonary Disease: The EMERGE Study. [PDF]

Drugs Real World Outcomes
Balamurugan S, Pophale H, Samariya U, Apte K, Singh S, Dhar R, Rajan S, Swarnakar R, Talwar D, Lopez M, Naik V, Sawant S, Chhowala S, Vaidya A, Gogtay J.   +14 more
europepmc   +1 more source

FF/UMEC/VI and BUD/GLY/FORM in Patients with COPD Stepping Up from Dual Therapy Stratified by Exacerbations and Prior Dual Therapy: A Subgroup Analysis of a Comparative Effectiveness Study. [PDF]

Adv Ther
Wedzicha JA, Noorduyn SG, Di Boscio V, Le Rouzic O, Majumdar A, Paczkowski R, Weng S, Germain G, Laliberté F, Mannino D.   +9 more
europepmc   +1 more source

A Strategy to Reduce Out-of-User-Life Utilization and Waste of Expired Budesonide-Formoterol Pressurized Metered-Dose Inhalers in Mild Asthma. [PDF]

Ann Am Thorac Soc
Stein KR, Jost E, Barker AR, Simkovich SM, Goss CW, Agarwal M, Huffman MD, Sumino K, Pleasants R, Castro M, Reddel HK, Krings JG.   +11 more
europepmc   +1 more source

A Comparison of the Molecular Pharmacological Properties of Current Short, Long, and Ultra-Long-Acting β₂-Agonists Used for Asthma and COPD. [PDF]

Pharmacol Res Perspect
Proudman RGW, Baker JG.
europepmc   +1 more source

Cost-effectiveness modeling of mortality risk reduction comparing two fixed-dose combination triple therapies in moderate-to-very severe chronic obstructive pulmonary disease. [PDF]

J Comp Eff Res
Parsekar K, Pandey S, Tansey-Dwyer D, Marshall J, Rustignoli I, Pollack M, Singh B, Ouwens M.   +7 more
europepmc   +1 more source

Formoterol Fumarate [PDF]

, 2020
openaire   +1 more source

An anti-inflammatory reliever algorithm approach to asthma management in adults: an open-label, single-arm trial. [PDF]

EClinicalMedicine
Bruce P, Houghton C, Hatter L, Kearns C, Holliday M, Anderson AJ, Perry M, Boyd C, Eathorne A, Martindale J, Sparks J, Semprini A, Pavord I, Harrison T, Papi A, Horne R, Weatherall M, Beasley R.   +17 more
europepmc   +1 more source

Economic evaluation of single-inhaler triple therapy for chronic obstructive pulmonary disease in Thailand. [PDF]

BMJ Open Respir Res
Dilokthornsakul P, Dilokthornsakul P, Chongmelaxme B, Niyompattama A.   +3 more
europepmc   +1 more source

Correction: Real-world Comparative Effectiveness in Patients with Asthma Newly Initiating Fluticasone Furoate/Vilanterol or Budesonide/Formoterol: A United Kingdom General Practice Cohort Study. [PDF]

Pulm Ther
Woodcock A, Blakey J, Bourdin A, Canonica GW, Domingo C, Ford A, Hulme R, Tritton T, Palomares I, Sadhu S, Biswas A, Verma M.   +11 more
europepmc   +1 more source

Correction to: Real-World Comparative Effectiveness Study in Patients with Asthma Initiating Fluticasone Furoate/Vilanterol or Beclometasone Dipropionate/ Formoterol Fumarate in General Practice in England. [PDF]

Adv Ther
Woodcock A, Blakey J, Bourdin A, Canonica GW, Domingo C, Ford A, Hulme R, Tritton T, Palomares I, Sadhu S, Biswas A, Verma M.   +11 more
europepmc   +1 more source